2. Academic Validation
  3. Tellimagrandin II, A Type of Plant Polyphenol Extracted from Trapa bispinosa Inhibits Antibiotic Resistance of Drug-Resistant Staphylococcus aureus

Tellimagrandin II, A Type of Plant Polyphenol Extracted from Trapa bispinosa Inhibits Antibiotic Resistance of Drug-Resistant Staphylococcus aureus

  • Int J Mol Sci. 2019 Nov 18;20(22):5790. doi: 10.3390/ijms20225790.
Yu-Wei Chang 1 2,  Wan-Chun Huang 3,  Chun-Yu Lin 1 3 4,  Wen-Hung Wang 3 4,  Ling-Chien Hung 3 4,  Yen-Hsu Chen 3 4 5 6
Affiliations

Affiliations

  • 1 Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • 2 Department of Laboratory, Taitung Hospital, Ministry of Health and Welfare, Taitung 95043, Taiwan.
  • 3 School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center of Tropical Medicine and Infectious diseases, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
  • 4 Division of Infectious Disease, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan.
  • 5 Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 80145, Taiwan.
  • 6 Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, HsinChu 30010, Taiwan.
PMID: 31752109 DOI: 10.3390/ijms20225790
Abstract

The emergence of methicillin-resistant Staphylococcus aureus (MRSA) has become a critical global concern. Identifying new candidates of anti-S. aureus agents is urgently required because the therapeutic strategies for infected patients are limited currently. Therefore, the present study investigated whether Tellimagrandin II (TGII), a pure compound extracted from the shells of Trapa bispinosa, exhibits Antibacterial effects against MRSA. We first showed that TGII exerted potent inhibitory activity against MRSA with a minimum inhibitory concentration of 128 μg/mL. The obtained fractional inhibitory concentration suggested that TGII could alone exert antistaphylococcal activity, and TGII combined with low doses of Antibiotics displayed synergistic effects against MRSA. Moreover, we found that TGII exerted bactericidal activity by reducing the expression of mecA followed by the negative regulation of the penicillin-binding protein 2a (PBP2a) of MRSA. Transmission electron microscopy (TEM) images further confirmed that TGII destroyed the integrity of the cell wall of MRSA and caused the loss of cytoplasm content. In conclusion, we evidenced the Antibacterial effects of TGII against MRSA, which enables the effective dose of current Antibiotics to be reduced and the predicament of drug-resistant S. aureus isolates to be overcome.

Keywords

MRSA; TGII; combination therapy; synergistic effect.

Figures
Products